Mirum Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US6047491013

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Michael G Grey. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Michael G Grey har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:MIRM / Mirum Pharmaceuticals, Inc. Director 186.410
US:HZNP / Horizon Therapeutics Plc Director 0
US:RPHM / Reneo Pharmaceuticals, Inc. Executive Chairman, Director 0
US:SPRB / Spruce Biosciences, Inc. Executive Chairman, Director 22.500
US:BMRN / BioMarin Pharmaceutical Inc. Director 0
US:MRTX / Mirati Therapeutics, Inc. Director 2.155
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Michael G Grey. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb MIRM / Mirum Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i MIRM / Mirum Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MIRM / Mirum Pharmaceuticals, Inc. Insider Trades
Insidersalg MIRM / Mirum Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i MIRM / Mirum Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MIRM / Mirum Pharmaceuticals, Inc. Insider Trades
Insiderkøb SPRB / Spruce Biosciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i MIRM / Mirum Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SPRB / Spruce Biosciences, Inc. Insider Trades
Insidersalg SPRB / Spruce Biosciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i MIRM / Mirum Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SPRB / Spruce Biosciences, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Michael G Grey som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-10-01 2024-09-27 4 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
G - Gift -102.788 186.410 -35,54
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -10.000 0 -100,00 116,50 -1.165.000
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -48.031 0 -100,00 116,50 -5.595.612
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -39.361 0 -100,00 116,50 -4.585.556
2023-09-28 2023-09-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 20.000 39.361 103,30 15,96 319.200 628.202
2023-09-14 2023-09-14 4 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
S - Sale X -14.216 0 -100,00 32,00 -454.912
2023-09-14 2023-09-14 4 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
M - Exercise 14.216 14.216 2,94 41.738 41.738
2023-09-14 2023-09-13 4 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
S - Sale X -392 0 -100,00 32,00 -12.544
2023-09-14 2023-09-13 4 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
M - Exercise 392 392 2,94 1.151 1.151
2023-07-27 2023-07-26 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock
G - Gift -50.000 0 -100,00
2023-06-09 2023-06-08 4 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
S - Sale X -14.608 0 -100,00 29,00 -423.632
2023-06-09 2023-06-08 4 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
M - Exercise 14.608 14.608 2,94 42.889 42.889
2023-05-04 2023-05-03 4 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
S - Sale X -14.608 0 -100,00 28,00 -409.024
2023-05-04 2023-05-03 4 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
M - Exercise 14.608 14.608 2,94 42.889 42.889
2023-05-02 2023-04-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 3.913 19.361 25,33
2022-09-02 2022-08-31 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock
M - Exercise 50.000 50.000 1,97 98.500 98.500
2022-05-27 2022-05-25 4 SPRB SPRUCE BIOSCIENCES, INC.
Stock Option (Right to Buy)
A - Award 22.500 22.500
2022-05-02 2022-04-29 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
M - Exercise -4.223 0 -100,00
2022-05-02 2022-04-29 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -1.139 65.374 -1,71 98,56 -112.260 6.443.261
2022-05-02 2022-04-29 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 4.223 66.513 6,78
2022-05-02 2022-04-28 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
A - Award 3.913 3.913
2021-12-20 2021-12-16 4 SPRB SPRUCE BIOSCIENCES, INC.
Employee Stock Option (right to buy)
A - Award 50.000 50.000
2021-07-23 2021-07-22 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -5.000 0 -100,00
2021-07-23 2021-07-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -4.000 0 -100,00 100,05 -400.200
2021-07-23 2021-07-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.000 4.000 -20,00 100,00 -100.000 400.000
2021-07-23 2021-07-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 5.000 5.000 2,37 11.850 11.850
2021-06-08 2021-06-04 4 MIRM Mirum Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 17.000 17.000
2021-05-21 2021-05-20 4 SPRB SPRUCE BIOSCIENCES, INC.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2021-04-30 2021-04-30 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
M - Exercise -11.098 0 -100,00
2021-04-30 2021-04-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2.993 70.395 -4,08 94,62 -283.198 6.660.775
2021-04-30 2021-04-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 11.098 73.388 17,82
2021-04-30 2021-04-29 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
A - Award 4.223 4.223
2021-04-15 2021-04-13 4 RPHM Reneo Pharmaceuticals, Inc.
Series A Preferred Stock
C - Conversion -90.222 0 -100,00
2021-04-15 2021-04-13 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock
C - Conversion 20.162 444.762 4,75
2021-04-15 3/A RPHM Reneo Pharmaceuticals, Inc.
Common Stock
424.600
2021-04-13 2021-04-12 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -15.000 5.000 -75,00
2021-04-13 2021-04-12 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -15.000 0 -100,00 90,28 -1.354.200
2021-04-13 2021-04-12 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 15.000 15.000 2,37 35.550 35.550
2021-04-12 2021-04-08 4 RPHM Reneo Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 14.000 14.000
2021-04-08 3 RPHM Reneo Pharmaceuticals, Inc.
Common Stock
134.084
2021-04-08 3 RPHM Reneo Pharmaceuticals, Inc.
Common Stock
424.601
2021-03-09 2021-03-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise -5.000 0 -100,00
2021-03-09 2021-03-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -5.000 42.840 -10,45 76,28 -381.400 3.267.835
2021-03-09 2021-03-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 5.000 47.840 11,67 26,49 132.450 1.267.282
2021-01-20 2021-01-15 4 MRTX Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy)
A - Award 2.155 2.155
2021-01-20 2021-01-15 4 MRTX Mirati Therapeutics, Inc.
Common Stock
A - Award 1.475 5.731 34,66
2020-12-16 2020-12-14 4 MRTX Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy)
M - Exercise X -10.900 0 -100,00
2020-12-16 2020-12-14 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -89 4.256 -2,05 249,42 -22.198 1.061.532
2020-12-16 2020-12-14 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -1.019 4.345 -19,00 248,55 -253.269 1.079.934
2020-12-16 2020-12-14 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -1.997 5.364 -27,13 247,62 -494.502 1.328.247
2020-12-16 2020-12-14 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -1.807 7.361 -19,71 246,73 -445.834 1.816.149
2020-12-16 2020-12-14 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -1.284 9.168 -12,28 245,11 -314.725 2.247.195
2020-12-16 2020-12-14 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -1.653 10.452 -13,66 244,45 -404.083 2.555.037
2020-12-16 2020-12-14 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -1.815 12.105 -13,04 243,34 -441.671 2.945.691
2020-12-16 2020-12-14 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -857 13.920 -5,80 242,29 -207.641 3.372.652
2020-12-16 2020-12-14 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -379 14.777 -2,50 241,22 -91.422 3.564.508
2020-12-16 2020-12-14 4 MRTX Mirati Therapeutics, Inc.
Common Stock
M - Exercise X 10.900 15.156 256,11 16,84 183.556 255.227
2020-08-07 2020-08-05 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -1.755 0 -100,00
2020-08-07 2020-08-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.755 0 -100,00 73,35 -128.729
2020-08-07 2020-08-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 1.755 1.755 3,95 6.932 6.932
2020-08-05 2020-08-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X -2.500 5.000 -33,33
2020-08-05 2020-08-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2.500 42.840 -5,51 120,35 -300.875 5.155.794
2020-08-05 2020-08-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2.500 45.340 5,84 26,49 66.225 1.201.057
2020-07-22 2020-07-22 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -1.755 1.755 -50,00
2020-07-22 2020-07-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.755 0 -100,00 60,00 -105.300
2020-07-22 2020-07-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 1.755 1.755 3,95 6.932 6.932
2020-06-26 2020-06-25 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -1.755 3.510 -33,33
2020-06-26 2020-06-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.755 0 -100,00 55,00 -96.525
2020-06-26 2020-06-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 1.755 1.755 3,95 6.932 6.932
2020-06-15 2020-06-11 4 MIRM Mirum Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 17.000 17.000
2020-05-29 2020-05-27 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4.300 42.840 11,16
2020-05-26 2020-05-22 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -10.530 0 -100,00
2020-05-26 2020-05-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale -10.530 0 -100,00 48,77 -513.505
2020-05-26 2020-05-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 10.530 10.530 7,84 82.555 82.555
2020-05-04 2020-05-02 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
M - Exercise -15.390 0 -100,00
2020-05-04 2020-05-02 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 15.390 62.290 32,81
2020-05-04 2020-04-30 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
A - Award 11.098 11.098
2020-01-07 2020-01-03 4 MRTX Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy)
A - Award 4.000 4.000
2020-01-07 2020-01-03 4 MRTX Mirati Therapeutics, Inc.
Common Stock
A - Award 2.000 4.256 88,65
2020-01-02 2020-01-01 4 MIRM Mirum Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 100.000 100.000
2019-11-14 2019-11-12 4 MRTX Mirati Therapeutics, Inc.
Non-Qualified Stock Option (Right to Buy)
M - Exercise X -3.500 10.900 -24,31
2019-11-14 2019-11-12 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -3.042 2.256 -57,42 102,44 -311.622 231.105
2019-11-14 2019-11-12 4 MRTX Mirati Therapeutics, Inc.
Common Stock
M - Exercise X 3.500 5.298 194,66 16,84 58.940 89.218
2019-08-14 2019-08-12 4 MRTX Mirati Therapeutics, Inc.
Non-Qualified Stock Option (Right to Buy)
M - Exercise X -3.500 14.400 -19,55
2019-08-14 2019-08-12 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -260 1.798 -12,63 93,98 -24.434 168.968
2019-08-14 2019-08-12 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -650 2.058 -24,00 93,18 -60.569 191.772
2019-08-14 2019-08-12 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -1.100 2.708 -28,89 92,34 -101.575 250.059
2019-08-14 2019-08-12 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -1.032 3.808 -21,32 91,20 -94.119 347.291
2019-08-14 2019-08-12 4 MRTX Mirati Therapeutics, Inc.
Common Stock
M - Exercise X 3.500 4.840 261,19 16,84 58.940 81.506
2019-07-24 2019-07-22 4 MIRM Mirum Pharmaceuticals, Inc.
Series A Prefered Stock
C - Conversion -63.585 0 -100,00
2019-07-24 2019-07-22 4 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
C - Conversion 7.948 289.198 2,83
2019-07-17 3 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
656.250
2019-07-17 3 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
468.750
2019-07-17 3 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
656.250
2019-07-17 3 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
468.750
2019-07-17 3 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
656.250
2019-07-17 3 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
468.750
2019-06-06 2019-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4.430 38.540 12,99
2019-05-15 2019-05-13 4 MRTX Mirati Therapeutics, Inc.
Non-Qualified Stock Option (Right to Buy)
M - Exercise X -7.100 17.900 -28,40
2019-05-15 2019-05-13 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -300 1.340 -18,29 66,08 -19.825 88.549
2019-05-15 2019-05-13 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale X -5.460 1.640 -76,90 65,26 -356.314 107.025
2019-05-15 2019-05-13 4 MRTX Mirati Therapeutics, Inc.
Common Stock
M - Exercise X 7.100 7.100 16,84 119.564 119.564
2019-05-06 2019-05-03 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
M - Exercise -15.320 0 -100,00
2019-05-06 2019-05-03 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -4.132 46.900 -8,10 26,54 -109.663 1.244.726
2019-05-06 2019-05-03 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 15.320 51.032 42,90
2019-05-06 2019-05-02 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units
A - Award 15.390 15.390
2019-01-22 2019-01-17 4 MRTX Mirati Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 11.000 11.000
2018-06-07 2018-06-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4.300 34.110 14,42
2018-05-07 2018-05-03 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 15.320 15.320
2018-05-07 2018-05-03 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 32.161 32.161
2018-05-07 2018-05-03 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -14.054 0 -100,00
2018-05-07 2018-05-03 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -3.790 35.712 -9,59 13,87 -52.567 495.325
2018-05-07 2018-05-03 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 14.054 39.502 55,23
2018-01-22 2018-01-18 4 MRTX Mirati Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 10.000 10.000
2017-06-08 2017-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 4.910 4.910
2017-06-08 2017-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 2.050 29.810 7,38
2017-05-19 2017-05-17 4 MRTX Mirati Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 10.000 10.000
2017-05-10 2017-05-10 4 HZNP Horizon Pharma plc
Ordinary Shares
P - Purchase 10.000 25.448 64,73 9,48 94.800 241.247
2017-05-04 2017-05-03 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 14.054 14.054
2017-05-04 2017-05-03 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 31.153 31.153
2017-05-04 2017-05-03 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -13.953 0 -100,00
2017-05-04 2017-05-03 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -3.763 15.448 -19,59 15,12 -56.897 233.574
2017-05-04 2017-05-03 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 13.953 19.211 265,37
2016-06-08 2016-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 4.440 4.440
2016-06-08 2016-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 1.510 27.760 5,75
2016-05-19 2016-05-18 4 MRTX Mirati Therapeutics, Inc.
Option Grant (Right to Buy)
A - Award 10.000 10.000
2016-05-10 2016-05-06 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -5.258 0 -100,00
2016-05-10 2016-05-06 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 5.258 5.258
2016-05-05 2016-05-03 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 13.953 13.953
2016-05-05 2016-05-03 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 23.092 23.092
2016-02-23 2016-02-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X -7.500 0 -100,00
2016-02-23 2016-02-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -7.500 26.250 -22,22 80,00 -600.000 2.100.000
2016-02-23 2016-02-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 7.500 33.750 28,57 38,59 289.425 1.302.412
2015-11-18 2015-11-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X -7.500 7.500 -50,00
2015-11-18 2015-11-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -7.500 26.250 -22,22 104,27 -782.054 2.737.187
2015-11-18 2015-11-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 7.500 33.750 28,57 38,59 289.425 1.302.412
2015-06-18 2015-06-10 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) common stock
A - Award 3.300 3.300
2015-06-18 2015-06-10 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 1.100 26.250 4,37
2015-05-22 2015-05-21 4 MRTX Mirati Therapeutics, Inc.
Option Grant (Right to Buy)
A - Award 15.000 15.000
2015-05-08 2015-05-06 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 5.258 5.258
2015-05-08 2015-05-06 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 8.548 8.548
2014-11-06 2014-11-05 4 MRTX Mirati Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -10.530 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -20.000 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -20.000 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -5.265 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 10.530 10.530
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 20.000 20.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 20.000 20.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 5.265 5.265
2014-06-30 2014-06-27 4 HZNP HORIZON PHARMA, INC.
Non-qualified stock options
A - Award 20.000 20.000
2014-06-06 2014-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 2.100 25.150 9,11
2014-06-06 2014-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) common stock
A - Award 6.600 6.600
2013-12-13 2013-12-11 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option Right to Buy
M - Exercise -7.500 7.500 -50,00
2013-12-13 2013-12-11 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -7.500 7.500 -50,00
2013-12-13 2013-12-11 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -15.000 0 -100,00
2013-12-13 2013-12-11 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -30.000 23.050 -56,55 69,66 -2.089.680 1.605.571
2013-12-13 2013-12-11 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 7.500 53.050 16,47 26,49 198.675 1.405.294
2013-12-13 2013-12-11 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 15.000 45.550 49,10 21,51 322.650 979.780
2013-12-13 2013-12-11 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 7.500 30.550 32,54 17,33 129.975 529.432
2013-06-03 2013-05-31 4 HZNP HORIZON PHARMA, INC.
Non-qualified stock options
A - Award 20.000 20.000
2013-05-17 2013-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
A - Award 8.500 8.500
2013-05-17 2013-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 3.400 23.050 17,30
2013-03-08 2013-03-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -15.000 0 -100,00
2013-03-08 2013-03-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -15.000 19.650 -43,29 60,61 -909.135 1.190.967
2013-03-08 2013-03-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 15.000 34.650 76,34 14,39 215.850 498.614
2013-02-22 2012-06-08 4 HZNP HORIZON PHARMA, INC.
Non-qualified stock options
A - Award 5.265 5.265
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
A - Award 8.500 76.000 12,59
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 3.400 19.650 20,92
2012-02-24 2012-02-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise 30.000 67.500 80,00
2012-02-24 2012-02-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
D - Sale to Issuer 30.000 16.250 -218,18 35,36 1.060.785 574.592
2012-02-24 2012-02-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 30.000 46.250 184,62 16,92 507.600 782.550
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)